Thrombotic microangiopathy and acute kidney injury following vivax malaria

Aditi Sinha, Arvind Bagga(All India Institute of Medical Sciences), Ashima Gulati(All India Institute of Medical Sciences), Abdus Sami Bhat(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Sanjay Kumar Agarwal(Institute of Botany), Geetika Singh(All India Institute of Medical Sciences), Sarita Mohapatra(All India Institute of Medical Sciences), J. C. Samantaray(All India Institute of Medical Sciences), Amit Kumar Dinda(All India Institute of Medical Sciences)
Clinical and Experimental Nephrology
July 3, 2012
10.1007/s10157-012-0656-9
Cited by 38

Related Papers

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216